Informations générales (source: ClinicalTrials.gov)

NCT06318117 Complet
Observational Study on the Use of Infant Formulas Based on Rice Protein Hydrolysate in Real Life Conditions
Observational
Mead Johnson Nutrition (Voir sur ClinicalTrials)
mars 2024
décembre 2025
02 février 2026
The main purpose of this study is to describe the pattern of RIF consumption in real life conditions, whatever the reasons of initiation and the chosen formula. The main objective is to study the reasons for prescribing a RIF during the first year of life, as per the pediatrician. Consumption started before 6 months of age, when milk and infantile formulas predominates in the baby's feeding, is of particular interest.
 Voir le détail

Etablissements

Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données
HOPITAL NOVO ENGLENDER En recrutement IDF 18/09/2025 17:50:10  Contacter
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
HOPITAL NOVO Contact (sur clinicalTrials)
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Centre Hospitalier d'Auxerre - Neonatology and pediatric emergency department - 89011 - Auxerre 3035843 - Auxerre - France Contact (sur clinicalTrials)
Centre Hospitalier de Montauban - Pediatric Department - Montauban 2993002 - Montauban - France Contact (sur clinicalTrials)
Centre Hospitalier Universitaire de Nantes - Pediatric emergency department - 44093 - Nantes 2990969 - Nantes - France Contact (sur clinicalTrials)
Dr Christine REGIMBART - Private Practice - 49026 - Bécon-les-Granits 3033927 - Becon-les-Granits - France Contact (sur clinicalTrials)
Dr Frederic Couttenier Private Practice - 59551 - Attiches 3036451 - France Contact (sur clinicalTrials)
Dr Marta Nowak-Mohamed - Private Practice - 03200 - Vichy 2969392 - Vichy - France Contact (sur clinicalTrials)
Dr. Amandine Blasquez Private Practice - 33500 - Libourne 2998517 - France Contact (sur clinicalTrials)
Dr. Anne Cheve Private Practice - 29200 - Brest 3030300 - France Contact (sur clinicalTrials)
Dr. Anne Sengier - Private Practice - 76600 - Le Havre 3003796 - LE Havre - France Contact (sur clinicalTrials)
Dr. Karim Abada Private Practice - 09017 - Foix 3018174 - France Contact (sur clinicalTrials)
Dr. Marc Sznajder Private Practice - 75011 - Paris 2988507 - France Contact (sur clinicalTrials)
Dr. Nellie Houeto Private Practice - 83400 - Hyères 3012937 - France Contact (sur clinicalTrials)
Dr. Piotr Gembara Private Practice - 03200 - Vichy 2969392 - France Contact (sur clinicalTrials)
Dr. Sandra Brancato Private Practice - 30190 - Brignon 3030055 - France Contact (sur clinicalTrials)
Elise Foy-Foulkes Private Practice - 92100 - Boulogne-Billancourt 3031137 - France Contact (sur clinicalTrials)
Scm Les Pediatrices Du Pic St Loup - 34980 - Saint-Clément 2981060 - DE Riviere - France Contact (sur clinicalTrials)

Critères

Tous


- Child aged between 6 and 36 months,

- Child who has already consumed a RIF for at least one month, or still consuming a
RIF, or who will benefit from taking a RIF, according to the pediatrician,

- Legal representatives (parents/guardians) deemed capable of following the
requirements of the protocol and have given their consent orally.

Exclusion Criteria:


- Child with a clinically relevant and significant abnormality in the medical history
or on physical examination;

- Child who has been hospitalized in a neonatology unit (due to prematurity,
malformation or neonatal pathology), or born with a low birth weight (≤ 2,500 g);

- For children not diversified at the time of starting RIF: mixed feeding with RIF and
breast milk and/or infant formula based on cow's milk;

- Child born to minor parent(s);

- Infant or infant's family unable to comply with study protocol or procedures, in the
judgment of the investigator;

- Participation in any other clinical trial prior to inclusion;

- Refusal of the Parents / legal representatives of the child, or who do not master
the French language well enough to understand the information letter.